What Drugs Can Make Your Nose Bleed?

Dozens of prescription and over-the-counter medications list nosebleeds as a side effect, but a handful of drug classes cause the vast majority of cases. Blood thinners top the list by a wide margin, followed by nasal sprays, antiplatelet drugs like aspirin, certain antidepressants, and targeted cancer therapies. Recreational drugs that are snorted add another well-documented category. The reasons differ depending on the drug, and so does the severity.

Blood Thinners Are the Most Common Cause

Anticoagulant drugs, the medications prescribed to prevent blood clots in conditions like atrial fibrillation and deep vein thrombosis, are the single biggest pharmacological cause of nosebleeds. Among anticoagulants, warfarin carries the highest risk. In a large propensity-matched study, warfarin users experienced clinically relevant nosebleeds at a rate roughly three times higher than users of newer alternatives like apixaban and rivaroxaban.¹ A separate nationwide analysis found warfarin was associated with about 2.2 nosebleed events per 100 person-years, compared to 0.6 for apixaban and 1.0 for rivaroxaban, with dabigatran producing no events at all during the study period.²

The newer direct oral anticoagulants, sometimes called DOACs, do still cause nosebleeds, just less often. Research has concluded that patients on DOACs do not have an increased risk of nosebleeds compared to other oral anticoagulants, and especially when compared to warfarin.³ If you are on warfarin and experiencing frequent nosebleeds, this is worth raising with your prescriber, since switching to a DOAC may substantially reduce the problem.

The mechanism here is straightforward: anticoagulants slow clotting throughout the body. The nose’s inner lining is packed with tiny, fragile blood vessels that sit just beneath the surface. Any minor irritation, a sneeze, dry air, rubbing your nose, can break one of those vessels. Without normal clotting speed, what would be a momentary trickle turns into a persistent bleed.

Aspirin and Other Antiplatelet Drugs

Aspirin works differently from anticoagulants. Rather than interfering with the clotting cascade, it makes platelets, the cell fragments that form the initial plug at a wound site, less sticky. That reduced stickiness means even small vessel breaks in the nose can bleed longer than they otherwise would. Aspirin is one of the drugs most frequently associated with drug-induced nosebleeds, alongside the anticoagulants already discussed.⁴

The picture gets more complicated when aspirin is combined with clopidogrel, a second antiplatelet drug commonly prescribed after heart stents. This dual antiplatelet regimen is known to increase bleeding risk across the board. Emergency department data show that for both dual antiplatelet therapy and warfarin, the majority of hemorrhage-related visits are for nosebleeds, skin bleeding, or other minor hemorrhages. The frequency of these minor bleeding events was similar between the two regimens, though warfarin-related cases were more likely to lead to hospitalization.⁵

For people taking low-dose aspirin for heart protection, occasional mild nosebleeds are usually manageable and not a reason to stop on your own. But if nosebleeds become frequent or hard to stop, your doctor needs to know, because the bleeding tendency reflects what is happening throughout your body, not just in your nose.

Nasal Corticosteroid Sprays

This one surprises many people. Fluticasone, mometasone, budesonide, and other steroid nasal sprays prescribed for allergies and chronic sinus problems are well-documented nosebleed triggers. A meta-analysis covering many trials found that intranasal corticosteroids as a class raised the relative risk of nosebleeds by about 48 percent compared to placebo. The sprays most strongly linked to nosebleeds were beclomethasone hydrofluoroalkane, fluticasone furoate, mometasone furoate, and fluticasone propionate, while ciclesonide formulations and beclomethasone aqueous were associated with the lowest risk.⁶

The cause is partly mechanical and partly pharmacological. The spray hits the nasal septum, the thin wall between your nostrils, at close range. Over time, the steroid thins the local tissue and the walls of small blood vessels, making them more prone to cracking. Technique matters: aiming the spray toward the outer wall of each nostril rather than straight at the septum reduces contact with the most vulnerable tissue. Many people never receive this instruction from their pharmacist, and it makes a real difference.

Interestingly, not all delivery methods carry the same risk. One study in children using budesonide delivered via a spacer rather than a direct nasal spray found no difference in nosebleeds compared to placebo.⁷ The more diffuse delivery pattern likely reduces the concentrated impact on the septum.

Over-the-Counter Nasal Decongestants

Oxymetazoline and similar decongestant sprays, sold under brand names you can pick up at any pharmacy, work by constricting blood vessels in the nasal lining to reduce swelling. Used briefly for a cold, they are generally safe. The trouble starts with prolonged use. As the body adapts, the receptors that respond to the drug become less sensitive, pushing people to spray more often and at higher doses. This cycle of rebound congestion and escalating use is a well-documented public health concern.⁸

The repeated vasoconstriction and rebound vasodilation takes a toll on the nasal lining. Blood vessels dilate and constrict in rapid cycles, the mucosa becomes irritated and fragile, and nosebleeds follow. People who have been using decongestant sprays daily for weeks or months often report nosebleeds as one of the first signs of damage. The standard advice, limiting use to three consecutive days, exists precisely to prevent this cascade.

Antidepressants, Especially Combined with Pain Relievers

Selective serotonin reuptake inhibitors, the class that includes fluoxetine, sertraline, and escitalopram, raise bleeding risk through a less obvious pathway. Serotonin plays a role in platelet activation, and by reducing the amount of serotonin available to platelets, these drugs modestly impair the blood’s ability to clot. Research indicates that serotonin reuptake inhibitors increase bleeding risk by roughly 1.2 to 2.4 times baseline.⁹

On its own, this elevated risk rarely causes problems for most people. The real danger emerges when SSRIs are combined with nonsteroidal anti-inflammatory drugs like ibuprofen or naproxen. The same research found the interaction between these drug classes to be synergistic, not just additive, with the combined odds ratio for bleeding events ranging from about 3 to 11 depending on the study.⁹ Since both drug types are extremely common and often taken simultaneously without a second thought, this interaction is underappreciated. If you take an SSRI and reach for ibuprofen regularly for headaches or joint pain, the combination may be why your nose keeps bleeding.

Targeted Cancer Therapies

A class of cancer drugs called antiangiogenic agents, designed to starve tumors by cutting off their blood supply, carries nosebleeds as one of the most frequent side effects. Bevacizumab is the best-known drug in this category. These medications work by blocking vascular endothelial growth factor (VEGF) signaling, which disrupts the maintenance and repair of blood vessel walls throughout the body, not just in tumors.¹⁰

Because VEGF is essential for keeping blood vessels intact, blocking it makes vessels fragile everywhere. The nose, with its dense network of superficial capillaries, is one of the first places this fragility becomes apparent. Oncologists generally expect mild nosebleeds in patients on these drugs and consider them manageable, but severe episodes do occur and require clinical attention. A review of drug-induced nosebleed cases noted that while most episodes from medications are mild or moderate, some require invasive interventions to control bleeding and avoid serious consequences.⁴

Cocaine and Other Snorted Drugs

Cocaine is notorious for causing nosebleeds, but the mechanism goes well beyond simple physical irritation from snorting a powder. Cocaine inhibits the reuptake of catecholamines, triggering intense vasoconstriction in the nasal lining. This chokes off blood supply to the tissue, causing ischemic injury and, over time, actual tissue death.¹¹ Early on, users experience nosebleeds. With continued use, the damage progresses to crusting, ulceration, and eventually perforation of the nasal septum, the wall between the nostrils.

Case reports document extreme outcomes including total destruction of both the bony and cartilaginous portions of the septum, saddle-nose deformity, and osteolytic sinusitis from chronic intranasal cocaine use.¹² This level of destruction is not limited to heavy, long-term users. The combination of vasoconstriction, local anesthetic effects masking the damage, and adulterants mixed into street cocaine all accelerate tissue breakdown. Nosebleeds in a cocaine user should be taken seriously as an early warning sign, not dismissed as a cosmetic nuisance.

Other drugs snorted recreationally or through misuse of prescription medications, including crushed pills, can cause nosebleeds through direct mechanical irritation to the nasal mucosa. The particles abrade the delicate lining and introduce contaminants. But cocaine stands apart because its pharmacological effects actively destroy the tissue from within, while the physical irritation compounds the damage from outside.

Sildenafil and Vasodilators

Sildenafil, better known by its brand name, works by preventing the breakdown of a molecule that relaxes smooth muscle in blood vessel walls. This vasodilation is the intended therapeutic effect for erectile dysfunction, but it is not limited to one part of the body. The nasal passages are rich in erectile tissue, similar in structure to the tissue the drug targets, and they respond to sildenafil with engorgement. That swelling stretches the walls of small blood vessels, which can rupture and bleed. Clinical reports have documented nosebleeds in men after taking sildenafil, attributed to this nasal mucosal engorgement.¹³

This side effect is generally mild and self-limiting, but it is more common than many users realize, partly because nasal congestion from the same mechanism is one of the drug’s most frequently reported side effects. The congestion and the nosebleeds share the same root cause. If you experience stuffiness after taking the drug, a nosebleed is the next step along the same physiological continuum.

How Multiple Drugs Stack the Risk

Many people take more than one of the drugs discussed here at the same time. An older adult on warfarin for atrial fibrillation who also uses a fluticasone nasal spray for allergies and takes occasional ibuprofen for arthritis is combining three separate nosebleed-promoting mechanisms: impaired clotting, thinned nasal tissue, and reduced platelet function. Each drug alone might produce only a small risk, but the combination can make nosebleeds a regular occurrence.

The SSRI-plus-NSAID interaction mentioned earlier is a good example of how combinations can be worse than the sum of their parts. But even without a formally synergistic interaction, additive effects matter. If your anticoagulant slightly impairs clotting and your nasal spray slightly weakens the blood vessels in your nose, the resulting nosebleed is more likely and harder to stop than either drug alone would cause. Pharmacists often catch these overlaps during medication reviews, which is one reason periodic reviews are worth doing even when nothing seems wrong.

What Makes the Nose So Vulnerable

The nose takes a disproportionate hit from blood-thinning and vessel-damaging drugs because of its anatomy. The front of the nasal septum contains a region called Kiesselbach’s plexus, where several small arteries converge into a dense web of capillaries just beneath a thin layer of mucosa. This tissue is exposed to air on every breath, making it prone to drying and cracking. It endures physical contact from nose-rubbing, nose-blowing, and the impact of nasal sprays. And it sits at the body’s surface, where temperature fluctuations between cold outdoor air and warm indoor heating cause repeated expansion and contraction of vessels.

None of these stresses would matter much if the blood vessels were buried deep in muscle or fat. But in the nose they are barely covered, separated from the air by a membrane thinner than a sheet of paper in some spots. This is why nosebleeds are one of the most sensitive early indicators of a drug’s effect on hemostasis, the body’s clotting and vessel-repair systems. Clinicians sometimes use the presence or absence of nosebleeds as a practical signal for whether a blood-thinning drug is pushing the body’s clotting system harder than intended.

An analysis of the FDA’s adverse event reporting database found that intranasal sprays across multiple categories generated epistaxis signals ranging widely in strength, with some drug-spray combinations showing reporting odds ratios above 27 for nosebleeds compared to baseline reporting rates.¹⁴ The nose, in other words, is exquisitely sensitive to chemical insults delivered both locally and systemically. That vulnerability is a feature of its design: the same rich blood supply that warms and humidifies inhaled air makes it the body’s most accessible bleeding point when drugs shift the balance.